Page last updated: 2024-10-21

pk 11195 and Neointima

pk 11195 has been researched along with Neointima in 2 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Neointima: The new and thickened layer of scar tissue that forms on a PROSTHESIS, or as a result of vessel injury especially following ANGIOPLASTY or stent placement.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Wu, LP1
Gong, ZF1
Wang, H2
Zhou, ZS1
Zhang, MM1
Liu, C1
Ren, HM1
Yang, J1
Han, Y2
Zeng, CY1
Gong, Z1
Wu, L1
Xia, T1
Ren, H1
Yang, D1
Gu, D1
Hu, C1
He, D1
Zhou, L1
Zeng, C1

Other Studies

2 other studies available for pk 11195 and Neointima

ArticleYear
TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation.
    Acta pharmacologica Sinica, 2020, Volume: 41, Issue:1

    Topics: AMP-Activated Protein Kinases; Animals; Becaplermin; Benzodiazepinones; Cell Movement; Cell Prolifer

2020
Translocator protein 18 kDa ligand alleviates neointimal hyperplasia in the diabetic rat artery injury model via activating PKG.
    Life sciences, 2019, Mar-15, Volume: 221

    Topics: Animals; Benzodiazepinones; Carotid Arteries; Carrier Proteins; Cell Movement; Cell Proliferation; C

2019